Visani, G <br/><br/>
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.  [electronic resource] 

 -  Leukemia  Jun 2001 
 - 903-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Review; Validation Study 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2402142  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Chromosome Aberrations<br/>Chromosome Deletion<br/>Chromosome Inversion<br/>Chromosomes, Human--ultrastructure<br/>Combined Modality Therapy<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Hepatomegaly--epidemiology<br/>Humans<br/>Idarubicin--administration & dosage<br/>Karyotyping<br/>Leukemia, Myeloid--drug therapy<br/>Male<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Prognosis<br/>Remission Induction<br/>Retrospective Studies<br/>Splenomegaly--epidemiology<br/>Survival Analysis<br/>Translocation, Genetic<br/>Treatment Outcome